Giving adolescents same-day access to long-acting reversible contraceptives (LARC) in a Medicaid setting may save insurers money, according to results of a new economic evaluation.
Giving adolescents same-day access to long-acting reversible contraceptives (LARC) in a Medicaid setting may save insurers money, according to results of a new economic evaluation. The authors of the report on the research, which appears in JAMA Network Open, said the model of care should be explored in other settings as a way to increase access to contraception and lower rates of unintended pregnancy.
The analysis was based on development of a decision model from the perspective of Medicaid in Indiana. The authors made some simple assumptions about a hypothetical base case: a 16-year-old patient who presented for care and wanted LARC. They said that the assumptions generally would bias against same-day LARC because they ignore some of the costs of unintended pregnancy.
Although insurers typically do not require two visits for insertion of LARC, in many clinics that is the process, according to the authors, because of barriers within clinical and billing systems and the cost of stocking LARC. To test the one-visit model, they used data from previous studies to work through all the scenarios that could result if an adolescent wanted same-day LARC. For each step, the cost to the payer was calculated-including expenses such as for the device itself, delivery of a baby, and cost of an annual visit.
Same-day LARC placement was associated with lower overall costs ($2016 per patient over 1 year) compared with placement at a subsequent visit ($4133 per patient over 1 year). Compared with the return-visit strategy, same-day LARC was associated with an unintended pregnancy rate of 14% versus 48% and an abortion rate of 4% versus 14%.
Describing the results, the authors said that this was “the first cost-minimization analysis done from the outpatient perspective. The cost savings calculated here provide a benchmark for policy makers to consider potential policy changes and investments in incentives to promote and provide same-day LARC.” Noting that Medicaid insures an at-risk, low-income population and covers almost half the births in the United States, the researchers recommended that the agency foster same-day access to contraception through four strategies:
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Identifying gaps in syphilis treatment and prenatal care among pregnant individuals
May 17th 2024Preventing congenital syphilis comes down to quick diagnosis and treatment of the infection in pregnancy, and the number of missed opportunities to do so in the United States continues to grow.
Read More